These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10715309)

  • 21. Optimization of peripheral blood stem cell mobilization.
    Demirer T; Buckner CD; Bensinger WI
    Stem Cells; 1996 Jan; 14(1):106-16. PubMed ID: 8820956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.
    Pecora AL; Preti RA; Gleim GW; Jennis A; Zahos K; Cantwell S; Doria L; Isaacs R; Gillio AP; Michelis MA; Brochstein JA
    J Clin Oncol; 1998 Jun; 16(6):2093-104. PubMed ID: 9626209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood stem cell mobilization for high-dose chemotherapy.
    Demirer T; Bensinger WI; Buckner CD
    J Hematother; 1999 Apr; 8(2):103-13. PubMed ID: 10349905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobilization of peripheral blood progenitor cells for allogeneic transplantation.
    Teshima A; Harada M
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):101-14. PubMed ID: 9287249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C; Isaacs A; Wong R; Chong BH
    Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose.
    Stewart DA; Guo D; Luider J; Auer I; Klassen J; Morris D; Chaudhry A; Brown C; Russell JA; Gluck S
    Bone Marrow Transplant; 2000 Feb; 25(4):435-40. PubMed ID: 10723588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation.
    Wiesneth M; Schreiner T; Friedrich W; Bunjes D; Duncker C; Krug E; Maccari B; Müller S; Nowak S; Kubanek B
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S21-4. PubMed ID: 9712487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery.
    Shpall EJ; Champlin R; Glaspy JA
    Biol Blood Marrow Transplant; 1998; 4(2):84-92. PubMed ID: 9763111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy.
    Josefsen D; Forfang L; Dyrhaug M; Blystad AK; Stokke T; Smeland EB; Kvalheim G
    Eur J Haematol; 2011 Dec; 87(6):494-502. PubMed ID: 21752097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
    Villalón L; Odriozola J; Laraña JG; Zamora C; Pérez de Oteyza J; Jodra MH; López J; Herrera P; Roldán E; Ramos ML; Ramos P; Navarro JL
    Hematol J; 2000; 1(6):374-81. PubMed ID: 11920217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
    Bolwell B; Goormastic M; Andresen S; Koo A; Wise K; Overmoyer B; Pohlman B; Kalaycio M
    Bone Marrow Transplant; 1998 Sep; 22(6):547-51. PubMed ID: 9758341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.